Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.42 |
| ▸ | MGAM | O43451 | 2/20 | 0.42 |
| ▸ | SI | P14410 | 2/20 | 0.42 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19821814 | 0.93 | MGAM (0.42) | GAAMGAMSIMGAM2TSHR | |
| SCHEMBL620518 | 0.88 | LDHA (0.35) | GAAMGAMSIMGAM2TSHR | |
| SCHEMBL2059152 | 0.88 | GAA (0.48) | GAAMGAMSIMGAM2TSHR | |
| SCHEMBL28949349 | 0.85 | LMNA (0.40) | GAAMGAMSIMGAM2TSHR | |
| SCHEMBL28875947 | 0.84 | CA4 (0.40) | GAAMGAMSIMGAM2TSHR | |
| SCHEMBL30997363 | 0.84 | ALDH1A1 (0.32) | GAAMGAMSIMGAM2TSHR | |
| SCHEMBL19821874 | 0.84 | ALDH1A1 (0.32) | GAAMGAMSIMGAM2TSHR | |
| SCHEMBL2380925 | 0.84 | ALDH1A1 (0.39) | GAAMGAMSIMGAM2TSHR | |
| SCHEMBL142215 | 0.84 | TSHR (0.39) | GAAMGAMSIMGAM2TSHR | |
| SCHEMBL5524337 | 0.82 | ALDH1A1 (0.38) | GAATSHRALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109232259-B | Preparation method of nitroacetophenone | 浙江理工大学 | 2021-05-28 | — | — | CN | claimed |
| CN-109503469-B | Preparation method of 2-acetylpyridine | 浙江理工大学 | 2020-08-04 | — | — | CN | claimed |
| EP-0261442-B1 | MALONIC ACID DERIVATIVES | NIHON NOHYAKU CO., LTD. (JP) | 1991-11-13 | — | — | EP | claimed |
| US-12577373-B2 | Carbodiimide composition, curing agent composition, coating composition and resin cured product | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2026-03-17 | — | — | US | disclosed |
| CN-120118286-A | Water-dispersible blocked isocyanate, fiber treating agent, water repellent agent, coating composition, and adhesive | 三井化学株式会社 | 2025-06-10 | — | — | CN | disclosed |
| CN-120118458-A | Curable composition, resin, and cured product | 东京应化工业株式会社 | 2025-06-10 | — | — | CN | disclosed |
| CN-119937242-A | Photosensitive resin composition | 东京应化工业株式会社 | 2025-05-06 | — | — | CN | disclosed |
| CN-119604592-A | Aqueous coating composition and method for forming multilayer coating film | 关西涂料株式会社 | 2025-03-11 | — | — | CN | disclosed |
| CN-116323837-B | Polyurethane curing agent and application thereof | 旭化成株式会社 | 2024-10-25 | — | — | CN | disclosed |
| CN-118742206-A | Antibacterial agent | 三井化学株式会社 | 2024-10-01 | — | — | CN | disclosed |
| EP-3771720-B1 | BLOCKED POLYISOCYANATE COMPOSITION, RESIN COMPOSITION, RESIN FILM AND LAMINATE | ASAHI CHEMICAL IND (JP) | 2024-05-01 | — | — | EP | disclosed |
| US-20140030528-A1 | MULTILAYER COATING FILM-FORMING METHOD AND COATED | KANSAI PAINT CO., LTD. (JP) | 2014-01-30 | — | — | US | disclosed |
| US-20140031484-A1 | BLOCK POLYISOCYANATE COMPOUND | KANSAI PAINT CO., LTD. (JP) | 2014-01-30 | — | — | US | disclosed |
| CN-101501002-B | Non-nucleoside reverse transcriptase inhibitors | HOFFMANN LA ROCHE | 2012-06-27 | — | — | CN | disclosed |
| WO-2012021446-A2 | PROCESS FOR PREPARING ALISKIREN AND ITS INTERMEDIATES | DR. REDDY'S LABORATORIES LTD. (IN) | 2012-02-16 | — | — | WO | disclosed |
| US-20110045191-A1 | MIXED-BLOCKED POLYISOCYANATES AND USES THEREOF | JONES RICHARD GARFIELD | 2011-02-24 | — | — | US | disclosed |
| WO-2010136360-A2 | BENZYLIDENE MALONATES | BASF SE (DE) | 2010-12-02 | — | — | WO | disclosed |
| CN-101501002-A | Non-nucleoside reverse transcriptase inhibitors | HOFFMANN LA ROCHE (CH) | 2009-08-05 | — | — | CN | disclosed |
| US-20040067318-A1 | Mixed-blocked polyisocyanates and uses thereof | BAXENDEN CHEMICALS LIMITED (GB) | 2004-04-08 | — | — | US | disclosed |
| US-5849855-A | Blocked polyisocyanate composition and one-pack thermocuring resin composition comprising the same | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1998-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577373-B2 | Carbodiimide composition, curing agent composition, coating composition and resin cured product | CD38, PARP9, MCCC2 | GAA 2462/4885MGAM 1246/4885SI 2460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.